Research Articles | Page 11 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes? Dec 2012 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence? Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Myelodysplastic syndromes: State of the art pathology, diagnosis and management Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
More is better: Combination therapies for myelodysplastic syndromes Mar 2015 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Myelodysplastic syndromes (MDS) Mar 2015 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)